Bivalirudin Infusion for Ventricular Infarction Limitation
Status:
Terminated
Trial end date:
2016-06-14
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether the use of bivalirudin will reduce extent of
the damage done to the heart muscle in participants who suffered a heart attack, compared to
the comparator treatment (heparin).